Amphastar Pharmaceuticals (AMPH) Financial Analysis & Valuation | Quarter Chart
Amphastar Pharmaceuticals (AMPH)
AMPHPrice: $19.02
Fair Value: 🔒
🔒score
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and A... more
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and ... more
Description
Shares
| Market Cap | $838.65M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | US | CEO | Yongfeng Zhang |
| IPO Date | 2014-06-25 | CAGR | 0.14% |
| Employees | 2,028 | Website | www.amphastar.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 3.02% | Total Yield | 3.02% |
AMPH chart loading...
Fundamentals
Technicals
| Enterprise Value | $1.40B | P/E Ratio | 6.49 |
| Forward P/E | 6.26 | PEG Ratio | -0.16 |
| P/S Ratio | 1.76 | P/B Ratio | 1.71 |
| P/CF Ratio | 7.84 | P/FCF Ratio | 9.52 |
| EPS | $2.93 | EPS Growth 1Y | -39.86% |
| EPS Growth 3Y | -7.26% | EPS Growth 5Y | 3516.56% |
| Revenue Growth 1Y | -1.06% | Gross Margin | 0.47% |
| Operating Margin | 0.16% | Profit Margin | 0.11% |
| ROE | 0.1% | ROA | 0.05% |
| ROCE | 0.08% | Current Ratio | 3.85 |
| Quick Ratio | 2.82 | Cash Ratio | 1.04 |
| Debt/Equity | 0.89 | Interest Coverage | 4.53 |
| Altman Z Score | 2.16 | Piotroski Score | 6 |